Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Lorne Hopfner Insider Profile
11 Followers
Robert Lorne Hopfner, Director at Hyperion Therapeutics, holds 0.00 shares in Hyperion Therapeutics (Ticker: HPTX), holds 1.57M shares in Inozyme Pharma (Ticker: INZY), holds 2.27M shares in Rallybio (Ticker: RLYB). Most recently, Robert Lorne Hopfner ― shares of Hyperion Therapeutics on ― for an estimated value of ―.
Robert Lorne Hopfner Hyperion Therapeutics (HPTX)Director
Hyperion Therapeutics (HPTX)
Director
Ranked #28,518 out of 98,564 Corporate Insiders
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
+4.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Lorne Hopfner holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Lorne Hopfner
Robert Lorne Hopfner's Trading History
Hyperion Therapeutics
―
―
―
―
Vaxcyte
Feb 04, 2021
Director
Uninformative Sell
427.07K
$109.90M
Inozyme Pharma
Aug 03, 2023
Director
Informative Buy
4.00M
$6.90M
Rallybio
Aug 04, 2021
Director
Uninformative Buy
―
$4.01M
List of latest transactions for each holding click on a transaction to see Robert Lorne Hopfner's performance on stock
You May Also Like
Robert Lorne Hopfner insider profile FAQ
What is the percentage of profitable transactions made by Robert Lorne Hopfner?
The percentage of profitable transactions made by Robert Lorne Hopfner is 38%.
What is the average return per transaction made by Robert Lorne Hopfner?
The average return per transaction made by Robert Lorne Hopfner is 4.50%.
What stocks does Robert Lorne Hopfner hold?
Robert Lorne Hopfner holds: HPTX, PCVX, INZY, RLYB stocks.
What was Robert Lorne Hopfner’s latest transaction?
Robert Lorne Hopfner latest transaction was an Uninformative Buy of ―.
What was Robert Lorne Hopfner's most profitable transaction?
Robert Lorne Hopfner’s most profitable transaction was an Informative Buy of INZY stock on March 30, 2023. The return on the trade was 63.30%.
What is Robert Lorne Hopfner's role in Hyperion Therapeutics?
Robert Lorne Hopfner's role in Hyperion Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.